Melton L J, Atkinson E J, O'Connor M K, O'Fallon W M, Riggs B L
Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
J Bone Miner Res. 1998 Dec;13(12):1915-23. doi: 10.1359/jbmr.1998.13.12.1915.
We evaluated different definitions of osteoporosis in a population-based sample of 348 men (age 22-90 years) compared with 351 women (age 21-93 years). Thirty-six men (10%) and 46 women (13%) had a history of osteoporotic fracture (hip, spine, or distal forearm due to moderate trauma at >/= age 35). In logistic regression analysis, osteoporotic fracture risk was associated with bone mineral density (BMD) at all sites (neck, trochanter, total hip, lumbar spine, and total wrist) in both genders (p < 0.001) except spinal BMD in men. After adjusting for age, total hip BMD was the strongest predictor of fracture risk in women (odds ratio [OR] per 1 SD decline, 2.4; 95% confidence interval [CI], 1.6-3.7), while wrist BMD was best in men (OR, 1.5; 95% CI, 1.1-2.0). Among men but not women, bone mineral apparent density (BMAD) was a better predictor of fracture than BMD (wrist BMAD OR, 1.7; 95% CI, 1.3-2.3). Hip BMD/BMAD decreased linearly from age 20 years onward in both genders, while spinal BMD/BMAD declined after age 40 in women but not in men. In both genders, total wrist BMD/BMAD decreased after age 50. By World Health Organization criteria, the age-adjusted prevalence of osteoporosis at the hip, spine, or wrist was 35% among women >/=50 years of age. A similar approach (BMD > 2.5 SD below the young male mean) produced an osteoporosis prevalence rate in men >/=50 years of age of 19%. Thus, bone density predicts fracture risk in men as it does in women, and the prevalence of osteoporosis in men, using sex-specific normal values, is substantial. These observations indicate a need for better prevention and treatment strategies for men.
我们在一个基于人群的样本中评估了骨质疏松症的不同定义,该样本包括348名男性(年龄22 - 90岁)和351名女性(年龄21 - 93岁)。36名男性(10%)和46名女性(13%)有骨质疏松性骨折病史(髋部、脊柱或远端前臂骨折,原因是35岁及以上时受到中度创伤)。在逻辑回归分析中,除男性脊柱骨密度外,骨质疏松性骨折风险与男女所有部位(颈部、大转子、全髋、腰椎和全腕)的骨密度(BMD)均相关(p < 0.001)。在调整年龄后,全髋骨密度是女性骨折风险的最强预测指标(每标准差下降的比值比[OR]为2.4;95%置信区间[CI]为1.6 - 3.7),而腕部骨密度对男性最佳(OR为1.5;95% CI为1.1 - 2.0)。在男性而非女性中,骨矿物质表观密度(BMAD)比骨密度是更好的骨折预测指标(腕部BMAD的OR为1.7;95% CI为1.3 - 2.3)。男女的髋部BMD/BMAD从20岁起均呈线性下降,而女性脊柱BMD/BMAD在40岁后下降,男性则不然。在男女中,全腕BMD/BMAD在50岁后均下降。按照世界卫生组织标准,50岁及以上女性髋部、脊柱或腕部经年龄调整后的骨质疏松患病率为35%。类似的方法(骨密度低于年轻男性平均值2.5个标准差以上)得出50岁及以上男性的骨质疏松患病率为19%。因此,骨密度在男性中与在女性中一样能预测骨折风险,并且使用性别特异性正常值时,男性骨质疏松的患病率相当可观。这些观察结果表明需要为男性制定更好的预防和治疗策略。